Institutionelle bei Genzyme

Daten für GENZYME.

Im Folgenden steht an erster Stelle der Name des institutionellen Shareholders bzw. Fonds, an zweiter Stelle die Anzahl der gehaltenen Aktien und an dritter Stelle der Wert des gehaltenen Aktienpakets.

Institutionelle Shareholder
Citigroup Inc. 17,438,925 $709,241,079
Massachusetts Financial Services Co - Other 12,547,218 $510,295,356
Wellington Management Company 8,198,308 $333,425,186
Putnam Investment Management, Inc. 6,850,628 $278,615,040
Morgan Stanley 6,279,502 $255,387,346
Barclays Bank Plc 5,927,469 $241,070,164
FMR Corporation (Fidelity Management & Research Corp) 5,692,154 $231,499,903
State Street Corporation 4,407,678 $179,260,264
Vanguard Group, Inc. (The) 3,939,287 $160,210,802
Invesco Funds Group, Inc. 3,755,100 $152,719,917

Topliste der investierten Fonds
Smith Barney Aggressive Growth Fund Inc. 5,500,000 $223,685,000
Homestead Funds Inc-Nasdaq 100 Index Tracking Stock Fund 4,786,524 $194,667,931
Vanguard Specialized-Health Care Fund 4,755,840 $193,420,012
Van Kampen Emerging Growth Fd 2,500,000 $101,675,000
Putnam Health Sciences Trust 2,120,800 $86,252,936
Massachusetts Investors Growth Stock Fund 1,963,000 $79,835,210
Fidelity Select Portfolios - Biotechnology 1,878,300 $76,390,461
College Retirement Equities Fund-Stock Account 1,620,955 $65,924,239
Eaton Vance Tax-Managed Growth Portfolio 1,600,000 $65,072,000
Scudder Growth and Income Fund 1,482,500 $60,293,275